Gene · 53345
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic evidence that FGF21 signaling reduces problematic alcohol use and alcohol-related liver disease. | J Hepatol | 2026 | 41747774 | PubTator, text mining | PubMed |
| MASLD: time to optimise regional research priorities. | Lancet Reg Health Southeast Asia | 2026 | 41743214 | PubTator, text mining | PubMed |
| MetALD: A narrative review of the clinical and molecular landscape of reclassifying steatotic liver disease. | Alcohol Clin Exp Res (Hoboken) | 2026 | 41736181 | PubTator, text mining | PubMed |
| Childhood Obesity: A Multisystem Challenge Linking Hypertension, NAFLD, and Sleep Apnea. | Med Sci (Basel) | 2026 | 41718117 | PubTator, text mining | PubMed |
| Factors associated with protection from MASLD in type 2 diabetes: A prospective study integrating longitudinal MRI/MRE and stable isotope tracing. | JHEP Rep | 2026 | 41716746 | PubTator, text mining | PubMed |
| Pathogenesis and intervention strategies for metabolic dysfunction-associated fatty liver disease from the perspective of the gut-microbiota-liver axis. | Front Immunol | 2026 | 41716420 | PubTator, text mining | PubMed |
| Multi-omics SMR and experimental supportive analyses decipher causal drivers hepatocellular carcinoma. | BMC Cancer | 2026 | 41699549 | PubTator, text mining | PubMed |
| Cross-ancestry genome-wide association studies of liver function biomarkers uncover pleiotropic variants, systemic disease links and therapeutic targets. | Genome Med | 2026 | 41689074 | PubTator, text mining | PubMed |
| Cross-trait genomic modeling reveals the polygenic architecture and systemic impact of MASLD. | Sci Adv | 2026 | 41686896 | PubTator, text mining | PubMed |
| TF-rs1049296 C>T Variant Modifies the Association between Hepatic Iron Stores and Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease. | J Clin Transl Hepatol | 2026 | 41659995 | PubTator, text mining | PubMed |
| Integration of PNPLA3 and TM6SF2 genotypes provides incremental improvement in advanced fibrosis prediction among MASLD patients with type 2 diabetes mellitus. | JHEP Rep | 2026 | 41624490 | PubTator, text mining | PubMed |
| The Emerging Challenge of Non-Cirrhotic MASLD-Related Hepatocellular Carcinoma: Etiology, Immunopathology, and Precision Oncology. | Liver Cancer | 2026 | 41607858 | PubTator, text mining | PubMed |
| Genetic Variants in Liver Cirrhosis: Classifications, Mechanisms, and Implications for Clinical Practice. | J Pers Med | 2026 | 41590522 | PubTator, text mining | PubMed |
| A deep ensemble encoder network method for improved polygenic risk score prediction. | BioData Min | 2026 | 41580836 | PubTator, text mining | PubMed |
| Mendelian Randomization With Longitudinal Exposure Data: Simulation Study and Real Data Application. | Stat Med | 2026 | 41567108 | PubTator, text mining | PubMed |
| Noninvasive strategies for metabolic dysfunction-associated steatotic liver disease assessment and referral in Japan. | World J Gastroenterol | 2026 | 41551835 | PubTator, text mining | PubMed |
| Clinical and Preclinical Obesity in Korean Adults from 2014 to 2023. | Diabetes Metab J | 2026 | 41531290 | PubTator, text mining | PubMed |
| The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease. | Ann Hepatol | 2026 | 41520698 | PubTator, text mining | PubMed |
| PNPLA3 and TM6SF2 exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis. | JHEP Rep | 2026 | 41492318 | PubTator, text mining | PubMed |
| The impact of genetic and environmental risk factors on adverse liver outcomes. | Int J Cancer | 2026 | 41345374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53345/papers?page=4